GLO1 and neoplasm: In summary, targeted GLO1 inhibition therapy can effectively improve the sensitivity of tumor treatment by selectively utilizing the accumulation of MG toxicity in cancer cells, especially showing outstanding value in the treatment of drug-resistant tumors.